EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for ELTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -2.114
March 31, 2026 -2.344
December 31, 2025 -2.561
September 30, 2025 -3.397
June 30, 2025 -4.180
March 31, 2025 -4.163
December 31, 2024 -4.448
September 30, 2024 -4.110
June 30, 2024 -3.996
March 31, 2024 -5.793
December 31, 2023 -12.92
September 30, 2023 -219.65
June 30, 2023 -445.08
March 31, 2023 -674.67
Date Value
December 31, 2022 -671.14
September 30, 2022 -458.51
June 30, 2022 -237.08
March 31, 2022 -10.80
December 31, 2021 -21.70
September 30, 2021 -36.46
June 30, 2021 -37.19
March 31, 2021 -38.33
December 31, 2020 -27.17
September 30, 2020 -22.81
June 30, 2020 -16.82
March 31, 2020 -9.916
December 31, 2019 -5.432

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Precigen, Inc. -1.100
Agenus, Inc. 2.651
Amgen, Inc. 16.10
Anika Therapeutics, Inc. -0.2741
BioCryst Pharmaceuticals, Inc. -1.504